Ketamine Therapy in Georgia

Ketamine therapy in Georgia is governed by a combination of federal and state regulations that work in tandem to ensure patient safety and appropriate clinical oversight. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning any practitioner who administers or prescribes it must hold a valid DEA registration. In Georgia, the medical use of ketamine falls under the authority of the Georgia Composite Medical Board (GCMB), which oversees physician licensing, prescribing authority, and standards of care. Clinics operating in Georgia must ensure that all administering providers hold current, unrestricted Georgia medical licenses and comply with both state and federal controlled substance regulations.

Georgia does not currently have a specific statutory framework that exclusively governs ketamine infusion clinics, so these facilities are generally regulated under broader medical practice and outpatient clinic standards. Clinics that administer ketamine intravenously are typically required to maintain appropriate facility standards, including protocols for patient monitoring, emergency response, and medication storage. Key compliance considerations for Georgia ketamine providers typically include:

• Valid DEA registration for all prescribing and administering physicians
• Compliance with Georgia Pharmacy Board rules regarding controlled substance storage and recordkeeping
• Thorough patient screening, informed consent documentation, and medical supervision throughout treatment
• Adherence to GCMB standards for professional conduct and scope of practice
• Proper maintenance of patient medical records in accordance with Georgia state law

It is important for patients seeking ketamine therapy in Georgia to verify that their chosen clinic operates under the direct supervision of a licensed medical physician or anesthesiologist, given ketamine's potential for adverse effects and its status as a controlled substance. Telemedicine-based ketamine services, which typically involve the prescription of oral or sublingual ketamine formulations, must also comply with Georgia's telemedicine regulations and the federal Ryan Haight Act, which governs the online prescribing of controlled substances. Patients and providers alike are encouraged to stay informed of any evolving state guidance, as the regulatory landscape surrounding ketamine therapy continues to develop alongside the broader growth of this treatment modality.